Research Articles
Cryopreserved vs. Freshly Cultured MSCs: A Systematic Analysis of Efficacy in Preclinical Inflammation Models
This article synthesizes current preclinical evidence on the therapeutic efficacy of cryopreserved mesenchymal stromal cells (MSCs) compared to freshly cultured cells in animal models of inflammation.
DMSO vs. DMSO-Free Cryoprotectants for MSCs: A Comprehensive Analysis for Clinical Translation
This article provides a critical comparison of DMSO-containing and DMSO-free cryoprotectants for Mesenchymal Stromal Cell (MSC) therapy, tailored for researchers and drug development professionals.
Fresh vs. Frozen: A Systematic Review of Cryopreserved vs. Freshly Cultured MSC Performance In Vivo
This article provides a comprehensive analysis for researchers and drug development professionals on the critical comparison between freshly cultured and cryopreserved Mesenchymal Stem/Stromal Cells (MSCs) for in vivo applications.
Overcoming Variability in Cryopreserved MSC Product Quality: A Strategic Guide for Standardization and Clinical Translation
Cryopreservation is indispensable for creating readily available, 'off-the-shelf' Mesenchymal Stromal Cell (MSC) therapies, yet it introduces significant challenges in maintaining consistent product quality, viability, and functionality.
Scaling Up Cryopreservation for Clinical MSC Doses: A Roadmap from Bench to Bioreactor
The transition of Mesenchymal Stromal Cell (MSC) therapies from clinical trials to widespread commercial use is critically dependent on scalable and robust cryopreservation processes.
Standardizing MSC Cryopreservation: A Roadmap for Reproducible Research and Clinical Translation
This article addresses the critical challenge of standardizing mesenchymal stromal cell (MSC) cryopreservation protocols across laboratories, a key hurdle in ensuring reproducible research and successful clinical translation.
Strategic Management of Apoptosis in Freshly Thawed Mesenchymal Stem Cells: A Guide for Enhanced Therapeutic Efficacy
The therapeutic success of Mesenchymal Stem Cell (MSC) transplantation is critically dependent on the viability and functionality of cells post-thaw.
Optimizing Cryoprotectant Removal in MSC Therapy: Protocols for Maximizing Viability and Clinical Safety
For researchers and drug development professionals, the effective removal of cryoprotectants like Dimethyl Sulfoxide (DMSO) post-thaw is a critical step in mesenchymal stromal cell (MSC) therapy manufacturing.
Optimizing Post-Thaw Viability of Cryopreserved MSCs: A Comprehensive Guide for Translational Research
This article provides a systematic review of evidence-based strategies to enhance the post-thaw viability, recovery, and functionality of cryopreserved Mesenchymal Stromal Cells (MSCs) for clinical applications.
Strategies for Reducing DMSO Toxicity in MSC Cryopreservation: From Foundational Science to Clinical Application
This comprehensive review addresses the critical challenge of dimethyl sulfoxide (DMSO) toxicity in mesenchymal stromal cell (MSC) cryopreservation, a key bottleneck in clinical cell therapy applications.